Stroke Trial, Recruiting NCT06728592 Sponsor: Chinese University of Hong Kong Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06728592
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel)
  • People who may be suitable for clot-busting medication and/or a procedure to remove the clot, and who can begin treatment within 6 hours of when they were last seen healthy
  • People who arrive at the emergency department between 8am and 6pm on weekdays
  • People (or their representatives) who understand Cantonese and are willing to provide written consent to take part in the study

Who may not be able to join:

  • People whose vital signs (such as heart rate or blood pressure) are unstable and require urgent medical attention
  • People for whom clot-busting medication or clot removal procedures are not safe, based on initial assessment — for example, those with unstable vital signs, a serious head injury within the past 3 months, or a known tendency to bleed
  • People who experience extreme anxiety in enclosed spaces (claustrophobia) or have other conditions that make MRI scanning unsuitable
  • People who have a pacemaker, a brain stimulator, or an insulin pump
  • People who have a medical or other condition that would prevent them from cooperating with the study procedures
  • Women who are pregnant or breastfeeding
  • People who have taken part in another clinical trial within the 3 months before being assessed for this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thomas Wai Hong LEUNG, MD, Chinese University of Hong Kong

Phone: 852-28902002

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 December 2024
Est. completion
31 December 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Door-to-Needle time(min) for intravenous thrombolysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov